Canada expanded and extended remission of qualifying U.S. surtaxes on November 9, 2026. The change affects more than future entries: eligible importers may now have four years after importation to make a remission claim, while new eligibility categories and product-specific exclusions make scope review important for companies importing U.S.-origin goods into the GTA.
What changed on November 9
The amended regulation extends horizontal remission of applicable U.S. surtaxes to June 30, 2028. It also expands eligibility to goods used by public education entities and to non-steel goods used in mining, quarrying, or oil and gas extraction. New product- and company-specific remission schedules were added at the same time. The Canada Gazette regulation states that the amendment came into force on November 9, 2026.
The most operationally significant change for historical entries is the extension of the claim period from two years to four years after importation. That does not make every past surtax payment recoverable. Importers generally still need to establish that the goods, use, importer, and applicable remission conditions fit the relevant measure, and they need supporting records.
Some products with Canadian production capacity are excluded from general horizontal remission. For that reason, an importer should not treat the extension as a blanket refund entitlement. The Finance Department’s remission guidance and schedules should be checked against the specific goods and transaction history.
Why the four-year window changes the review
The longer period creates a reason to revisit entries that may previously have been outside an internal recovery review. A manufacturer, distributor, or food-packaging operation in Mississauga, Brampton, or Toronto could have U.S.-origin inputs spread across several accounting periods. The practical question is not simply whether a line was subject to a surtax; it is whether the importer can connect that line to the qualifying use and preserve the evidence required by the applicable schedule.
- Identify U.S.-origin goods for which a Canadian surtax was paid.
- Separate entries by product, importer, end use, and applicable remission schedule.
- Check whether the goods fall within an excluded category or a product-specific condition.
- Reconcile candidate entries to commercial records and customs accounting data.
- Retain the documents supporting both eligibility and the amount claimed.
This is a review exercise rather than a reason to file indiscriminate claims. A four-year period increases the population of potentially relevant entries, but it also increases the need for a defensible audit trail.
How the claim work connects to CARM accounting
CBSA’s November 16 notice separately set out procedures for declaring, correcting, and adjusting surtax in CARM and the Commercial Accounting Declaration. For commercial goods subject to surtax, the notice describes the use of the “Subject” designation, the applicable surtax code, self-declared amounts where applicable, and the authorization code for a remission Order-in-Council when relief is claimed. It also identifies correction and reason-code requirements and calls for justification in the declaration remarks field for relevant corrections.
The CBSA CARM notice states that corrections may be submitted before the CAD payment due date and that refund or remission adjustments require supporting documents. It also warns that incomplete adjustment requests can be rejected and may fail to protect statutory time limits.
For an importer using a broker, this separates two controls that are often treated as one: determining whether the goods qualify for remission, and transmitting the claim or correction correctly in the accounting system. Broker instructions, internal approval records, and entry-level evidence should align before an adjustment is submitted.
What GTA importers should do next
Start with a screened entry population
Importers operating warehouses or distribution activity in the 401/407 corridor can begin with a report of U.S.-origin entries on which the relevant surtax was paid. The review should then filter for the newly listed uses, including qualifying manufacturing, processing, agricultural production, food or beverage packaging, mining, quarrying, and oil and gas extraction contexts described in the remission materials.
Do not overlook exclusions
The existence of a qualifying business activity does not resolve product scope. Importers should compare each product against the current remission schedules and the exclusion for certain products with Canadian production capacity. Where the result depends on a technical description or end use, the file should preserve the basis for that conclusion.
Coordinate the evidence before the adjustment
A remission file generally needs more than an entry number. The supporting record may need to connect the imported item to its origin, use, product description, and claimed treatment. The CARM instructions make the accounting presentation part of the compliance process, so the importer’s records and the broker’s declaration data should be reviewed together.
The immediate development is therefore not a new surtax rate. It is a broader and longer remission framework, with conditions that still need to be tested entry by entry. Importers that paid eligible U.S. surtaxes should assess the expanded four-year review period now, while keeping the claim tied to the applicable schedule and complete supporting records.
Sources and scope
This article addresses the November 9, 2026 remission amendment and the November 16, 2026 CARM accounting notice. It does not treat the change as a general GTA border restriction or as automatic relief for all U.S.-origin imports.

